Jubilant Pharmo
₹938.6+0.40 (+0.04%)as of 2026-10-16
- Market Cap
- ₹14,927Cr.
- P/E Ratio
- 38.5
- P/B Ratio
- 2.11
- EPS (TTM)
- ₹24.38
- Day Range
- ₹928.6 – ₹954.9
- Div Yield
- 0.5%
- ROCE
- 8.99%
- ROE
- 6.53%
52W Low: ₹78652W High: ₹1,185
Themes:💊 Pharma & CDMO
Descriptive screens built from published data — not investment advice.
At a glance
- Sales have grown 10.0% a year over three years.
- Debt is 0.51× its shareholders’ equity.
From reported financials and exchange prices. Descriptive only, not advice.
Jubilant_Pharmo — Price
Interval
Style
Failed: 503
Evenstocks Score
Middle third
Overall
Valuation
Quality
Fundamental
Growth
Investment Checklist
Quick assessment based on key parametersPerformance
N/ATrailing return unavailableValuation
P/E 38.5P/E: 38.5 | P/B: 2.11Growth
ModestSales CAGR — 3Y: 10% · 1Y: 16%Profitability
Low MarginROCE: 8.99% | ROE: 6.53%Key Metrics
Valuation
PEG Ratio 0.82
Price / Sales 1.73x
Book Value ₹445
Margins & returns
Operating Margin 14%
Net Margin 4.1%
Return on Assets 2.3%